Blog
RSS FeedPosted by Michael Wonder on 23 Mar 2020
COVID-19 and processing times
23 March 2020 - At present, TLV's operations continue as usual. ...
Posted by Michael Wonder on 18 Mar 2020
Professor Gillian Leng, CBE, appointed as new NICE Chief Executive
18 March 2020 - Gillian has held the post of Deputy Chief Executive at NICE since 2007 and is also currently ...
Posted by Michael Wonder on 16 Mar 2020
MPs back Nebhrajani as NICE’s new chair after vetting meeting
16 March 2020 - Sharmila Nebhrajani has been confirmed as the new chair of NICE after a pre-appointment hearing by ...
Posted by Michael Wonder on 06 Mar 2020
NICE chair nominee Nebhrajani to face MP scrutiny next week
5 March 2020 - The UK government’s preferred candidate to chair NICE – Sharmila Nebhrajani OBE – is due to ...
Posted by Michael Wonder on 02 Mar 2020
EMA organisational changes come into effect
2 March 2020 - As of today, EMA has implemented changes to its organisational structure. ...
Posted by Michael Wonder on 12 Jan 2020
The FDA is in trouble. Here’s how to fix it.
11 January 2020 - Some New Year’s resolutions for the incoming boss. ...
Posted by Michael Wonder on 16 Dec 2019
Senate confirms Stephen Hahn to head FDA
12 December 2019 - The Food and Drug Administration has been without a permanent commissioner since April, when Dr. Scott Gottlieb ...
Posted by Michael Wonder on 28 Nov 2019
Agneta Karlsson new Director General at TLV
28 November 2019 - Today the Government has appointed Agneta Karlsson as new Director General of the Authority Dental Care and ...
Posted by Michael Wonder on 25 Nov 2019
ICER opens nominations for new members of its voting panels
25 November 2019 - Independent panel members debate the evidence on the effectiveness and value of new drugs and other ...
Posted by Michael Wonder on 06 Nov 2019
Dr. Stephen Hahn nominated to be next FDA commissioner
6 November 2019 - The Trump administration on Tuesday formally nominated Dr. Stephen Hahn to be the next commissioner of ...
Posted by Michael Wonder on 06 Nov 2019
FDA Office of Hematology Oncology Products reorganises, renamed Office of Oncologic Diseases
6 November 2019 - The U.S. FDA’s office responsible for reviewing applications for new and existing cancer therapies has reorganized ...
Posted by Michael Wonder on 24 Oct 2019
Trump set to nominate Texas cancer doctor to head FDA
25 October 2019 - If confirmed, Stephen Hahn would succeed acting commissioner Norman “Ned” Sharpless. ...
Posted by Michael Wonder on 03 Oct 2019
Dr. Brian O’Rourke to retire as CADTH’s President and CEO
3 October 2019 - Dr. Brian O’Rourke has announced his intention to retire from CADTH, effective 31 March 2020. ...
Posted by Michael Wonder on 02 Oct 2019
Trump set to nominate Stephen Hahn as FDA commissioner, pending vetting process
1 October 2019 - President Trump is set to nominate Dr. Stephen Hahn to lead the Food and Drug Administration, ...
Posted by Michael Wonder on 26 Sep 2019
FDA begins reorganisation phase of modernisation efforts to increase efficiency and further support new drug development
26 September 2019 - Today, the U.S. FDA’s Center for Drug Evaluation and Research (CDER) announced that the reorganization of certain ...